Medical University of South Carolina

Open enrollment with an early-phase pipeline tilt

According to ClinicalTrials.gov-derived indexes, Medical University of South Carolina sits in the top decile of US sponsors by registered trial count (#44 of 15,742 sponsors by registered trial count).

755 total trials 142 currently recruiting 520 completed early-phase tilt top decile by trial count

Medical University of South Carolina: 755 sponsored US clinical trials, 142 recruiting.

Medical University of South Carolina sponsors 755 registered US clinical trials on ClinicalTrials.gov, 142 of them currently recruiting, and 520 completed. 66 of these trials are in Phase 3-4 (later-stage) and 228 in Phase 1-2 (earlier-stage). The most-studied condition in this pipeline is Stroke, with 15 trials.

Top-decile sponsor footprint

Medical University of South Carolina ranks in the top decile of sponsors by registered trial count (#44 of 15,742 sponsors by registered trial count). Volume at this scale usually reflects a long institutional pipeline, read phase tilt and therapeutic areas below before treating it as current-year activity.

Trial completion reliability score

D 64/100

520 of 580 decided trials (Completed vs. Terminated on ClinicalTrials.gov) reached their planned completion (89.7%), vs. national p10 68.4% / p90 100% among 1,234 sponsors with at least 10 decided trials. Still-open trials (Recruiting, Active-not-recruiting, Not-yet-recruiting) are excluded since they have not reached an outcome yet.

Open and recent trials

755 total, page 11 of 16

COMPLETED NA

Evaluation of the Effectiveness of tDCS in the Management of Perioperative Pain

NCT01861587

TERMINATED NA

Efficacy of Labor Epidurals for Postpartum Tubal Ligation

NCT02564016

COMPLETED Early Phase 1

The Effects of Theta Burst Stimulation on the Brain Response to Drug and Alcohol Cues

NCT02939352

COMPLETED NA

Tablet-Aided BehavioraL Intervention EffecT on Self-management Skills

NCT02128854

COMPLETED NA

Impact of Dural Puncture Epidural Versus Traditional Lumbar Epidural on Onset of Labor Analgesia

NCT02412969

COMPLETED

Observational Examination of Thermoregulation in Total Joint Arthroplasty

NCT02225743

COMPLETED NA

Innovative Delivery of Evidence Based Psychotherapy to Women With Military Sexual Trauma

NCT02417025

COMPLETED

Pediatric Blunt Abdominal Trauma Clinical Prediction Model

NCT02206698

COMPLETED NA

COAST: Coiling of Aneurysms Smaller Than 5mm With Hypersoft® and Hydrogel Coils

NCT02259504

COMPLETED NA

Positive Therapy for Autonomic Function & Mood in ICD Patients

NCT02088619

COMPLETED Phase 1

Ultrasound Guided Local Anesthetic Block: Thoracolumbar Interfascial Plane

NCT02297191

COMPLETED NA

Ultrathin Bronchoscope and Radial Endobronchial Ultrasound (R-EBUS) With Fluoroscopy Versus Standard Fiberoptic Bronchoscopy (FB) (P00029233 )

NCT02146131

COMPLETED NA

Tobacco Intervention in Primary Care Treatment Opportunities for Providers

NCT02096029

TERMINATED NA

Chronotherapy Randomized Controlled Trial

NCT02176824

COMPLETED NA

The Effect of Pre-Frontal tDCS on Sleep Propensity During an Afternoon Nap: RCT

NCT02176785

COMPLETED

Brain Connectivity Supporting Language Recovery in Aphasia

NCT02416856

COMPLETED NA

22-gauge ProCore Needle v. Standard 22-gauge (P00030500)

NCT02154698

COMPLETED NA

Repetitive Transcranial Magnetic Stimulation (rTMS) for Nicotine Addiction

NCT02401672

COMPLETED Phase 1

Testing a Promising Treatment for Youth Substance Abuse in a Community Setting

NCT02130479

TERMINATED Phase 1

The Better Resiliency Among Veterans With Omega-3's (BRAVO) Study

NCT01901887

COMPLETED Phase 1

Oxytocin Suppresses Substance Use Disorders Associated With Chronic Stress

NCT02058251

COMPLETED Phase 4

Novartis Everolimus Transition

NCT02096107

COMPLETED NA

TranQuill™ Sling Snoreplasty for Snoring and Mild Obstructive Sleep Apnea:

NCT02364518

COMPLETED NA

Coronary CT Angiography Using a Novel 3rd Generation Dual-Source CT System

NCT02218060

COMPLETED Phase 3

Achieving Cannabis Cessation-Evaluating N-Acetylcysteine Treatment

NCT01675661

COMPLETED NA

Efficacy of Serum Bovine Immunoglobulin in Improving Nutritional Status in Advanced COPD

NCT02067377

COMPLETED NA

Extinction Updating in Reconsolidation

NCT02154685

COMPLETED NA

Technology-Based Tools to Enhance Quality of Care in Mental Health Treatment

NCT01915160

COMPLETED NA

NeutraSal Treatment for Xerostomia in OSAS Patients Using CPAP Therapy

NCT02107300

COMPLETED Phase 1

Docetaxel and Lycopene in Metastatic Prostate Cancer

NCT01949519

COMPLETED Phase 1

An Interactive Computer Game, Called Duck Duck Punch, for Stroke Rehabilitation at Home and in a Rehabilitation Clinic

NCT02882997

COMPLETED NA

Yogic Breathing Changes Salivary Components

NCT02108769

COMPLETED NA

Feasibility and Tolerability of Adjunct Chronotherapy in Depressed Inpatients

NCT02088580

COMPLETED Phase 2

Enhancing Disrupted Reconsolidation: Impact on Cocaine Craving

NCT01822587

TERMINATED NA

POSITIVE Stroke Clinical Trial

NCT01852201

COMPLETED Phase 2

Herbal Mouthrinse for Oral Mucositis Study

NCT01898091

COMPLETED

ADAPT A Direct Aspiration, First Pass Technique for the Endovascular Treatment of Stroke

NCT01852227

COMPLETED NA

Wound Powder for Pressure Ulcers at End-of-life

NCT02008487

COMPLETED

Total Hip Arthroplasty Outcomes With Regional and Multimodal Analgesia

NCT02186795

COMPLETED Phase 1

Augmentation of Locomotor Adaptation Post-Stroke

NCT02892084

COMPLETED NA

Facebook for Social Skills Training in Autism: Project Rex Connect

NCT02897687

COMPLETED NA

Intervention to Improve Quality of Life in African American Lupus Patients

NCT01837875

COMPLETED NA

Effect of Oxytocin on Craving and Therapy Response

NCT01827332

COMPLETED NA

Randomized, Placebo-Controlled Study of an Herbal Tea to Support Lactation

NCT02190448

COMPLETED Phase 1

Phase I Assay-guided Trial of Anti-inflammatory Phytochemicals in Patients With Advanced Cancer

NCT01820299

COMPLETED NA

Aortic Stenosis Pre-Transcatheter Aortic Valve Replacement (TAVR) Procedure CT Scan

NCT01843426

COMPLETED Phase 4

Study of Effects of Sildenafil on Patients With Fontan Heart Circulation

NCT01815502

TERMINATED Phase 4

LARGE Aneurysm Randomized Trial: Flow Diversion Versus Traditional Endovascular Coiling Therapy

NCT01762137

COMPLETED NA

Reduction of Staph Aureus Carriage by Non-Antibiotic NOZIN® Nasal Sanitizer® Antiseptic

NCT01861457

COMPLETED NA

The Effect of tDCS Applied During Sleep on Memory Consolidation

NCT02596568

← Previous Page 11 of 16 Next →

Phase Distribution

PhaseTrial count
Phase 1 104
Phase 2 124
Phase 3 23
Phase 4 43

What is open in the Medical University of South Carolina pipeline

142 recruiting of 755 indexed (19% open); 520 completed (69%).

Phase mix: 66 late (III/IV) vs 228 early (I/II) (early-phase heavy).

Top condition: Stroke (15 trials), 9 others listed.

How open-pipeline share is computed

Recruiting share is recruiting_count divided by trial_count for this sponsor in the public registry export. Status can change between pulls; treat the figure as a research-attention snapshot, not product availability.

Medical University of South Carolina: open-pipeline peers nationwide

Peers matched on 755 registered trials and 19% open enrollment, not the therapeutic-area sidebar.

Medical University of South Carolina sits at or above the median trial volume and at or above the median recruiting share among these 9 nationwide peers -- the two do not always move together. Source: ClinicalTrials.gov (2026-08-08 snapshot). 2×2 strategic matrix plotting 9 entities by Total trials (X) and Recruiting share (Y), with a crosshair dividing the plot into four quadrants. Higher volume & more openFocused & more openHigher volume, mostly closedSmaller & mostly closed 02004006008001,000 14%16%18%20%22% Total trials Recruiting share Medical University of South CarolinaUniversity of California, San DiegoThe University of Texas Health Science Center, HoustonDana-Farber Cancer InstituteUniversity of MiamiSpaulding Rehabilitation HospitalIpsenEyePoint PharmaceuticalsHebrew SeniorLife
Medical University of South Carolina sits at or above the median trial volume and at or above the median recruiting share among these 9 nationwide peers -- the two do not always move together. Source: ClinicalTrials.gov (2026-08-08 snapshot).

Medical University of South Carolina sits at or above the median trial volume and at or above the median recruiting share among these 9 nationwide peers -- the two do not always move together.

Sponsors near 755 trials (± recruiting share)

Sponsors near 19% open enrollment (± trial volume)

What to do with this Medical University of South Carolina page

755 registered trials is a research-attention snapshot, not an endorsement of Medical University of South Carolina or any single study.

  • 142 of Medical University of South Carolina's trials are currently recruiting, check each one's own eligibility criteria before contacting a site. Browse recruiting trials
  • Stroke is the condition Medical University of South Carolina studies most, compare against other sponsors active in the same condition before evaluating a specific study. See Stroke trials
  • Bring the specific trial ID (NCT number) to your own doctor before enrolling, this page is a directory, not medical guidance. Read the trial-finding guide

Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. Medical University of South Carolina pipeline card: 755 registered trials from official public datasets. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.